Coronary Artery Disease
Ivascular S.L. is involved in clinical research focused on coronary artery disease, with attention to treatment strategies after stent implantation and the management of patients requiring ongoing antiplatelet therapy.
- Coronary stent therapy
- Dual antiplatelet therapy
- Bleeding risk in cardiovascular care
The sponsor’s research interest centers on balancing protection against target lesion failure with the reduction of clinically relevant bleeding in patients treated for coronary disease.
Interventional Cardiology
The clinical programme reflects a strong interest in interventional cardiology, especially outcomes associated with drug-eluting stents and comparative evaluation of device performance in routine cardiovascular practice.
- Stent performance
- Device-related coronary outcomes
- Post-procedural cardiovascular management
Research activity spans multiple collaborating sites across several countries, supporting investigation of coronary interventions in diverse clinical settings.
Antiplatelet Strategy Optimization
Another key therapeutic area is the optimisation of antiplatelet regimens after coronary intervention, including comparison of standard and abbreviated approaches in patients with coronary artery disease.
- Abbreviated antiplatelet therapy
- Standard dual antiplatelet therapy
- Bleeding Academic Research Consortium events
This work aligns with clinical questions around reducing bleeding complications while maintaining cardiovascular protection after stent placement.
Cardiovascular Device Evaluation
Ivascular S.L. also focuses on the evaluation of cardiovascular devices, with interest in how specific stent platforms perform in patients undergoing coronary treatment.
- Angiolite stent
- Xience stent family
- Target lesion failure
The sponsor’s clinical research includes comparative assessment of device-associated outcomes relevant to cardiology and vascular intervention.
